Response to: Remission of hidradenitis suppurativa after bariatric surgery
| Published in: | JAAD Case Reports |
|---|---|
| Main Authors: | Nicole Mona Golbari, BA, Martina Lee Porter, MD, Alexa Boer Kimball, MD, MPH |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-04-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617303028 |
Similar Items
Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
by: Peyton C. Morss-Walton, BA, et al.
Published: (2022-03-01)
by: Peyton C. Morss-Walton, BA, et al.
Published: (2022-03-01)
Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
by: Ruby S. Gibson, MD, et al.
Published: (2022-09-01)
by: Ruby S. Gibson, MD, et al.
Published: (2022-09-01)
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis
by: Charlotte Greif, MD, et al.
Published: (2024-03-01)
by: Charlotte Greif, MD, et al.
Published: (2024-03-01)
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
by: Ruby S. Gibson, MD, et al.
Published: (2024-10-01)
by: Ruby S. Gibson, MD, et al.
Published: (2024-10-01)
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
by: Corey L. Snyder, MD, et al.
Published: (2024-06-01)
by: Corey L. Snyder, MD, et al.
Published: (2024-06-01)
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
by: Simon J. Gunter, MPhil, et al.
Published: (2024-10-01)
by: Simon J. Gunter, MPhil, et al.
Published: (2024-10-01)
Lymphangioma circumscriptum as an untoward consequence of hidradenitis suppurativa surgery
by: Molly R. Marous, MD, et al.
Published: (2021-09-01)
by: Molly R. Marous, MD, et al.
Published: (2021-09-01)
Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient Tool for hidradenitis suppurativa specialty clinics
by: Zachary Wendland, MD, MPH, et al.
Published: (2025-04-01)
by: Zachary Wendland, MD, MPH, et al.
Published: (2025-04-01)
An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life
by: M.A. Storer, MS, et al.
Published: (2018-12-01)
by: M.A. Storer, MS, et al.
Published: (2018-12-01)
Surgical Management of Hidradenitis Suppurativa
by: Aleksandra Krajewski, MD, et al.
Published: (2024-06-01)
by: Aleksandra Krajewski, MD, et al.
Published: (2024-06-01)
Response to “Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient tool of hidradenitis suppurativa specialty clinics”
by: Terri Shih, MD, et al.
Published: (2025-04-01)
by: Terri Shih, MD, et al.
Published: (2025-04-01)
Multimodal management of hidradenitis suppurativa
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01)
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01)
Spironolactone in hidradenitis suppurativa: a single-center
by: Rahul Masson, BS, et al.
Published: (2024-03-01)
by: Rahul Masson, BS, et al.
Published: (2024-03-01)
The utility of upadacitinib to treat refractory hidradenitis suppurativa in an obese patient
by: Zahidul Islam, BA, et al.
Published: (2025-11-01)
by: Zahidul Islam, BA, et al.
Published: (2025-11-01)
Hidradenitis suppurativa in patients with and without erythrasma
by: Mariela Del Ángel Hernández, MD, et al.
Published: (2023-09-01)
by: Mariela Del Ángel Hernández, MD, et al.
Published: (2023-09-01)
Quality and engagement of online hidradenitis suppurativa information
by: Neha R. Shukla, MD, et al.
Published: (2021-09-01)
by: Neha R. Shukla, MD, et al.
Published: (2021-09-01)
De novo ectopic hidradenitis suppurativa versus classic ectopic hidradenitis suppurativa: A case series and review of the literature
by: Cassidy M. Nguyen, BS, et al.
Published: (2024-11-01)
by: Cassidy M. Nguyen, BS, et al.
Published: (2024-11-01)
Use of topical clascoterone for the treatment of hidradenitis suppurativa
by: Kaitlynne N. Cunningham, BS, et al.
Published: (2023-06-01)
by: Kaitlynne N. Cunningham, BS, et al.
Published: (2023-06-01)
Evaluating patients with hidradenitis suppurativa for disordered eating
by: Amina Ziad, BA, et al.
Published: (2024-03-01)
by: Amina Ziad, BA, et al.
Published: (2024-03-01)
Keratitis-ichthyosis-deafness syndrome and hidradenitis suppurativa
by: Lisa Travis, MD, et al.
Published: (2023-08-01)
by: Lisa Travis, MD, et al.
Published: (2023-08-01)
Wound care counseling of patients with hidradenitis suppurativa: perspectives of dermatologists
by: Sneha Poondru, BA, et al.
Published: (2023-10-01)
by: Sneha Poondru, BA, et al.
Published: (2023-10-01)
Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)
A case of late-onset Dowling-Degos disease with hidradenitis suppurativa
by: Catherine F. Sollitto, BA, et al.
Published: (2025-11-01)
by: Catherine F. Sollitto, BA, et al.
Published: (2025-11-01)
Mucopolysaccharidosis type IVA and severe hidradenitis suppurativa: A case series
by: Jorga Fialová, MD, et al.
Published: (2025-08-01)
by: Jorga Fialová, MD, et al.
Published: (2025-08-01)
Surgical Approach to Hidradenitis Suppurativa
by: L. Mateu-Arrom, et al.
Published: (2025-06-01)
by: L. Mateu-Arrom, et al.
Published: (2025-06-01)
Hidradenitis suppurativa and daily lifestyle
by: Natsuko Saito-Sasaki, et al.
Published: (2025-06-01)
by: Natsuko Saito-Sasaki, et al.
Published: (2025-06-01)
Leflunomide-Induced Hidradenitis Suppurativa
by: Achraf Machan, et al.
Published: (2020-01-01)
by: Achraf Machan, et al.
Published: (2020-01-01)
Dietary Factors and Hidradenitis Suppurativa
by: Alan S. Shen, et al.
Published: (2023-10-01)
by: Alan S. Shen, et al.
Published: (2023-10-01)
An Atlas of the Hidradenitis Suppurativa Transcriptome
by: Weronika Szukala, et al.
Published: (2024-01-01)
by: Weronika Szukala, et al.
Published: (2024-01-01)
Integrative management of hidradenitis suppurativa
by: Tushar P Shah, et al.
Published: (2024-01-01)
by: Tushar P Shah, et al.
Published: (2024-01-01)
Lack of association of exogenous testosterone administration with exacerbation of preexisting hidradenitis suppurativa
by: Kanika Kamal, BA, et al.
Published: (2024-06-01)
by: Kanika Kamal, BA, et al.
Published: (2024-06-01)
The use of tetracyclines in hidradenitis suppurativa: A focused systematic review
by: Zahidul Islam, BA, et al.
Published: (2025-09-01)
by: Zahidul Islam, BA, et al.
Published: (2025-09-01)
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes
by: Alexa B. Kimball, et al.
Published: (2024-01-01)
by: Alexa B. Kimball, et al.
Published: (2024-01-01)
Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
by: Ryan C. Saal, BS, et al.
Published: (2023-06-01)
by: Ryan C. Saal, BS, et al.
Published: (2023-06-01)
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
by: Alexander D. Woods, MD, et al.
Published: (2025-03-01)
by: Alexander D. Woods, MD, et al.
Published: (2025-03-01)
Optimizing hidradenitis suppurativa clinic visits: Patient perspectives
by: Terri Shih, BS, et al.
Published: (2022-10-01)
by: Terri Shih, BS, et al.
Published: (2022-10-01)
Racial Disparities in Hidradenitis Suppurativa Management at a Single Institution
by: Nikhi P. Singh, MD, MBA, et al.
Published: (2025-06-01)
by: Nikhi P. Singh, MD, MBA, et al.
Published: (2025-06-01)
Hidradenitis suppurativa in the setting of immune checkpoint inhibitor therapy: A case series
by: Liam M. Dalton, BA, et al.
Published: (2025-05-01)
by: Liam M. Dalton, BA, et al.
Published: (2025-05-01)
Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity
by: Radhika Gupta, BA, et al.
Published: (2025-08-01)
by: Radhika Gupta, BA, et al.
Published: (2025-08-01)
A Novel Treatment of Hidradenitis Suppurativa With Radical Unroofing and Deepithelialization
by: Dylan G. Choi, BS, et al.
Published: (2025-08-01)
by: Dylan G. Choi, BS, et al.
Published: (2025-08-01)
Similar Items
-
Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
by: Peyton C. Morss-Walton, BA, et al.
Published: (2022-03-01) -
Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
by: Ruby S. Gibson, MD, et al.
Published: (2022-09-01) -
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis
by: Charlotte Greif, MD, et al.
Published: (2024-03-01) -
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
by: Ruby S. Gibson, MD, et al.
Published: (2024-10-01) -
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
by: Corey L. Snyder, MD, et al.
Published: (2024-06-01)
